6-K - Anbio Biotechnology Class A Ordinary Shares | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Anbio Biotechnology filed a Form 6-K on February 17, 2026, attaching Exhibit 16.1, a letter from HTL International, LLC confirming agreement with statements concerning their firm in the filing. HTL International, LLC does not agree or disagree with other statements in the Form 6-K.

Key Takeaways

1Exhibit 16.1 dated February 17, 2026

2HTL International, LLC agrees with statements about their firm

3HTL International, LLC located at 12 Greenway Plaza Suite 1100, Houston, Texas 77046

4Letter addressed to SEC at 100 F Street, NE, Washington, D.C. 20549

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

Exhibits (2)

16.1

EXHIBIT 16.1

6-K

FORM 6-K